Stocktwits on MSN

NSPR rallies after hours on FDA green light for key stroke-prevention trial despite withdrawn annual guidance

Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial. ・Separately, the company also announced that it has initiated a voluntary recall in ...

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

(Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced that the U.S. Food and Drug Administration (“FDA”) has ...
Yahoo Finance

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD, Inc. (NSPR) has been beaten down lately with too much selling pressure. While the stock has lost 15.2% over the past four weeks, there is light at the end of the tunnel as it is now in ...

InspireMD to Announce First Quarter 2026 Financial Results

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its first quarter financial results on Monday, ...